Inside the Lemonaid Health Buy: Kyle Pretsch on Bambu Ventures’s Bold Play

Bambu Ventures's Kyle Pretsch dives into Lemonaid’s $10M buyout, down from 23andMe’s $400M price tag, and what’s next after Chrome Co.’s dramatic pivot.
More Videos
Can NYC Finally Cool Its Subway?
Why is the NYC subway platform so hot? One rider built his own sensor network to find out. We explore the geothermal fix the MTA is piloting right now.
Load More